The Online Investor
OLI Premium
Contrarian Outlook
Stock Option Ideas
Preferred Stock Newsletter
Affimed N.V. (AFMD)

Affimed is a holding company. Through its subsidiary, Co. is enagaged as a clinical-stage biopharmaceutical company focused on discovering and developing highly targeted cancer immunotherapies. Co.'s product candidates are developed in the field of immuno-oncology, which represents an innovative approach to cancer treatment that harnesses the body's own immune defenses to fight tumor cells. The more potent cells of the human defense arsenal are types of white blood cells called Natural Killer cells, or NK-cells, and T-cells. Co. focuses its research and development efforts on proprietary programs: AFM13, and AFM11.

AFMD SEC Filing Email Alerts Service

Company Name:  Affimed N.V.
Sector:  Drugs & Pharmaceuticals
Number of ETFs Holding AFMD:  8
Total Market Value Held by ETFs:  $5.19M
Total Market Capitalization:  $157.00M
% of Market Cap. Held by ETFs:  3.31%
November 14, 2019    4:45 PM Eastern

If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Quotes delayed 20 minutes

Strong Buy (4.00 out of 4)
100th percentile
(ranked higher than approx. 100% of all stocks covered)
Based on Zacks ABR data;
powered by Xignite

Affimed N.V. (AFMD) Page | The Online Investor | | Copyright © 1998 - 2019, All Rights Reserved

Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes, powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.